Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL

NCT06489808 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Large B-Cell Lymphoma

Interventions

DRUG: Linperlisib
DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Dexamethasone
DRUG: Cisplatin
DRUG: Ara-C
DRUG: Vinorelbine
DRUG: Mitoxantrone hydrochloride liposome

Sponsor

Institute of Hematology & Blood Diseases Hospital, China